Literature DB >> 7816642

Antisense pro-drugs: 5'-ester oligodeoxynucleotides.

N N Polushin1, J S Cohen.   

Abstract

Oligonucleotides bearing a terminal lipophilic group attached through a biodegradable ester bond should be useful as antisense pro-drugs with improved cellular uptake. The synthesis of 5'-ester oligonucleotides is, however, problematic due to lability of the ester bond during aqueous ammonia treatment that is commonly used for the deprotection of synthetic oligonucleotides. The synthesis of 5'-palmitoyl oligodeoxynucleotides was accomplished in good yield by the use of a combination of base-labile tert-butylphenoxyacetyl amino protecting groups (t-BPA), the oxalyl-CPG anchor group, and ethanolamine (EA) as a deprotecting reagent.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7816642      PMCID: PMC332106          DOI: 10.1093/nar/22.24.5492

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  21 in total

1.  GEM 91--an antisense oligonucleotide phosphorothioate as a therapeutic agent for AIDS.

Authors:  S Agrawal; J Y Tang
Journal:  Antisense Res Dev       Date:  1992

2.  Synthesis of alkylating oligonucleotide derivatives containing cholesterol or phenazinium residues at their 3'-terminus and their interaction with DNA within mammalian cells.

Authors:  A S Boutorin; L V Gus'kova; E M Ivanova; N D Kobetz; V F Zarytova; A S Ryte; L V Yurchenko; V V Vlassov
Journal:  FEBS Lett       Date:  1989-08-28       Impact factor: 4.124

3.  Synthesis, hybridization properties and antiviral activity of lipid-oligodeoxynucleotide conjugates.

Authors:  R G Shea; J C Marsters; N Bischofberger
Journal:  Nucleic Acids Res       Date:  1990-07-11       Impact factor: 16.971

4.  Labile exocyclic amine protection of nucleosides in DNA, RNA and oligonucleotide analog synthesis facilitating N-deacylation, minimizing depurination and chain degradation.

Authors:  N D Sinha; P Davis; N Usman; J Pérez; R Hodge; J Kremsky; R Casale
Journal:  Biochimie       Date:  1993       Impact factor: 4.079

5.  [Use of hydrazine for rapid deblocking of synthetic oligonucleotides].

Authors:  N N Polushin; I N Pashkova; O G Chakhmakhcheva; V A Efimov
Journal:  Bioorg Khim       Date:  1993-03

6.  On the rapid deprotection of synthetic oligonucleotides and analogs.

Authors:  N N Polushin; A M Morocho; B C Chen; J S Cohen
Journal:  Nucleic Acids Res       Date:  1994-02-25       Impact factor: 16.971

7.  Phosphorothioate-phosphodiester oligonucleotide co-polymers: assessment for antisense application.

Authors:  M K Ghosh; K Ghosh; J S Cohen
Journal:  Anticancer Drug Des       Date:  1993-02

8.  Cholesteryl-conjugated oligonucleotides: synthesis, properties, and activity as inhibitors of replication of human immunodeficiency virus in cell culture.

Authors:  R L Letsinger; G R Zhang; D K Sun; T Ikeuchi; P S Sarin
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

9.  In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides.

Authors:  M Z Ratajczak; J A Kant; S M Luger; N Hijiya; J Zhang; G Zon; A M Gewirtz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

10.  The final deprotection step in oligonucleotide synthesis is reduced to a mild and rapid ammonia treatment by using labile base-protecting groups.

Authors:  J C Schulhof; D Molko; R Teoule
Journal:  Nucleic Acids Res       Date:  1987-01-26       Impact factor: 16.971

View more
  2 in total

1.  Site-specific introduction of functional groups into phosphodiester oligodeoxynucleotides and their thermal stability and nuclease-resistance properties.

Authors:  Y Nomura; Y Ueno; A Matsuda
Journal:  Nucleic Acids Res       Date:  1997-07-15       Impact factor: 16.971

Review 2.  Nucleoside, nucleotide and oligonucleotide based amphiphiles: a successful marriage of nucleic acids with lipids.

Authors:  Arnaud Gissot; Michel Camplo; Mark W Grinstaff; Philippe Barthélémy
Journal:  Org Biomol Chem       Date:  2008-03-05       Impact factor: 3.876

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.